|
Volumn 176, Issue 12, 2002, Pages 573-574
|
The control of meningococcal disease
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMOXICILLIN;
ANTIBIOTIC AGENT;
ANTIBODY;
CEFOTAXIME;
CEFTRIAXONE;
MENINGOCOCCUS VACCINE;
PENICILLIN G;
POLYSACCHARIDE VACCINE;
PENICILLIN DERIVATIVE;
BACTERIAL ARTHRITIS;
BACTERIAL INFECTION;
BACTERIAL VIRULENCE;
BACTERIUM ISOLATION;
BLOOD ANALYSIS;
CAUSE OF DEATH;
CEREBROSPINAL FLUID ANALYSIS;
CHEMOPROPHYLAXIS;
CIGARETTE SMOKING;
COMMUNICABLE DISEASE;
CONJUNCTIVITIS;
DISEASE CONTROL;
DISEASE COURSE;
DISEASE PREDISPOSITION;
DOSE RESPONSE;
EDITORIAL;
EPIDEMIC MENINGITIS;
FEVER;
HUMAN;
LISTERIOSIS;
MENINGOCOCCOSIS;
MORTALITY;
NEISSERIA MENINGITIDIS;
NONHUMAN;
PNEUMONIA;
POLYMERASE CHAIN REACTION;
PRACTICE GUIDELINE;
PUBLIC HEALTH SERVICE;
RASH;
RISK FACTOR;
SEPTICEMIA;
SIDE EFFECT;
VACCINATION;
DIFFERENTIAL DIAGNOSIS;
ISOLATION AND PURIFICATION;
MICROBIOLOGY;
NASOPHARYNX;
DIAGNOSIS, DIFFERENTIAL;
HUMANS;
MENINGOCOCCAL INFECTIONS;
NASOPHARYNX;
NEISSERIA MENINGITIDIS;
PENICILLIN G;
PENICILLINS;
PUBLIC HEALTH PRACTICE;
|
EID: 0037124216
PISSN: 0025729X
EISSN: None
Source Type: Journal
DOI: 10.5694/j.1326-5377.2002.tb04586.x Document Type: Editorial |
Times cited : (8)
|
References (11)
|